Multibagger penny stock below ₹5 jumps over 4% after announcement of Q4 results 2025
Shares of Nandan Denim, a penny stock trading under ₹ 5, jumped over 4 percent in intra-day trading on Monday, May 26, after the company posted strong revenue growth for the quarter ended March 2025 (Q4FY25). The upbeat top-line performance reignited investor interest despite a notable decline in profitability.
Nandan Denim reported a sharp 81 percent surge in sales for the March 2025 quarter, with revenue climbing to ₹ 1,048.65 crore, compared to ₹ 579.12 crore in the same quarter last year. This strong growth underscores the company's expanding market presence and robust demand for its denim products both in India and internationally.
However, the bottom line failed to keep pace. The company's net profit for the quarter declined by 60.79 percent to ₹ 10.63 crore from ₹ 27.11 crore in the corresponding period of the previous year. The decline in profit despite higher revenue suggests increased cost pressures or changes in the product mix that impacted margins.
On an annual basis, net profit also dipped 25.50 percent, falling to ₹ 33.48 crore in FY25 from ₹ 44.94 crore in FY24. Yet, revenue for the year ended March 2025 rose substantially, up 76.44 percent to ₹ 3,546.68 crore, compared to ₹ 2,010.09 crore in the previous year.
The company has taken several shareholder-friendly initiatives in recent years. In September 2024, Nandan Denim announced a stock split in a 10:1 ratio, making the stock more affordable and accessible to retail investors. Earlier, in March 2022, it had issued bonus shares in a 2:1 ratio, further rewarding shareholders.
Founded in 1994, Nandan Denim is part of the Ahmedabad-based Chiripal Group and has grown to become India's largest and the world's fourth-largest denim fabric manufacturer. What began as a textile trading business has evolved into a vertically integrated denim powerhouse with global operations. Today, it exports to over 27 countries and counts several top retailers among its clients. Domestically, the company holds a dominant position in the denim supply chain.
The penny stock climbed as much as 4.2 percent in Monday's session, touching an intraday high of ₹ 4.19. Despite the rally, it remains 43 percent below its 52-week high of ₹ 7.33, which it touched in September 2024. The stock also hit a 52-week low of ₹ 2.96 in March 2025.
Over the past year, the stock has delivered a modest 5 percent return, reflecting a largely flat trajectory. However, a broader time-frame paints a more optimistic picture. Over two years, the stock has surged 92 percent, while in five years, it has given multibagger returns, skyrocketing by 755 percent—offering substantial wealth creation for long-term investors.
The recent uptrend has also been noteworthy. The stock has gained more than 13 percent so far in May, following a 3.7 percent rise in April and an 11.4 percent increase in March. Prior to this rally, the counter had been under pressure, declining for five straight months from October 2024 through February 2025.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
21 minutes ago
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
We're the largest gig worker employer in the country: Rapido cofounders
We're currently in over 35 cities with taxis and aim to be present in every district headquarters, says Rapido Surajeet Das Gupta Bengaluru Listen to This Article Bengaluru-based startup Rapido, which joined the unicorn club last year, has disrupted the mobility business by shifting from a commission to a subscription model for drivers across vehicle categories. It recently added taxis, prompting rivals Ola and Uber to follow suit. Rapido cofounders Pavan Guntupalli and Aravind Sanka, in an interview with Surajeet Das Gupta in Bengaluru, discuss their push to become a mass-market mobility player, ongoing goods and services tax (GST) and regulatory challenges, and the government's electric vehicle (EV) drive. Edited excerpts:
Time of India
an hour ago
- Time of India
Insurance firm directed to pay 11L for unfair trade practice in settling claim
Raipur: The Chhattisgarh state consumer disputes redressal commission directed an insurance firm backed by a public-sector bank to pay Rs 11,16,801 to a Raipur-based firm for deficiency in service and unfair trade practice in settling a vehicle insurance claim. The commission also awarded Rs 50,000 for mental agony and Rs 5,000 towards litigation costs. The order, passed by President Justice Gautam Chourdiya and Member Pramod Kumar Varma, set aside an earlier ruling by the District Consumer Disputes Redressal Commission, Raipur, which dismissed the complaint as premature. The commission noted that keeping the claim pending for an extended period, especially after the damaged vehicle was handed over as per the insurer's instructions, amounted to deficiency in service and unfair trade practice. "After accepting the surveyor's assessment, instructing disposal of the damaged vehicle, and its actual disposal, it was improper for the insurer to raise further objections. Keeping the claim pending despite receiving the wreck value amounts to deficiency in service and unfair trade practice. The insurer is liable to pay the remaining Rs 11,16,801, along with compensation for mental agony and litigation costs. The district commission erred in holding the claim premature, making its order unsustainable and liable to be set aside," remarked the consumer commission on the case. The firm's car, insured with the insurance firm, met with an accident on Nov 8, 2019. The insurance company assessed the loss at Rs 11,16,801 and instructed the complainant to hand over the damaged vehicle to a salvage buyer, who paid Rs 13,30,000. The firm alleged that despite these actions and assurances of payment, the remaining amount of Rs 11,16,801 was not disbursed. A complaint was filed before the district commission seeking the balance amount and compensation. The insurance firm, in its defence, said that the claim was pending as the complainant did not provide clarifications and relevant documents regarding the incident. The state commission, however, observed that the insurer already acted upon the surveyor's settlement recommendation and instructed the disposal of the vehicle's wreckage. The commission noted that after proceeding towards settlement and the disposal of the wreckage, it was improper for the insurer to raise further objections. The insurance company has been directed to pay the remaining assessed loss of Rs 11,16,801 with 6% annual simple interest from the date of filing the complaint until realisation, along with the compensation and litigation costs.
